Back to User profile » Dr Caicun Zhou

Papers published by Dr Caicun Zhou:

Case report

Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review

Chen S, He Y, Liu J, Chen X, Yu J, Li W, Chen B, Sun C, Zhou C

OncoTargets and Therapy 2019, 12:11305-11311

Published Date: 19 December 2019

Review

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer

Deng J, Zhao S, Zhang X, Jia K, Wang H, Zhou C, He Y

OncoTargets and Therapy 2019, 12:7347-7353

Published Date: 6 September 2019

Original Research

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial

Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C

OncoTargets and Therapy 2018, 11:8575-8587

Published Date: 30 November 2018

Original Research

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L

OncoTargets and Therapy 2018, 11:8565-8573

Published Date: 30 November 2018